{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:36:47Z","timestamp":1760747807126,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000380","name":"Guy's and St Thomas' Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ejca.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:16:11Z","timestamp":1587687371000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy"],"prefix":"10.1016","volume":"132","author":[{"given":"Federica","family":"Torricelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosamond","family":"Nuamah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Neat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Harling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"NG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Ciarrocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.03.002_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: the standard of care and challenges for future management","volume":"78","author":"van Meerbeeck","year":"2011","journal-title":"Crit Rev Oncol-Hematol"},{"key":"10.1016\/j.ejca.2020.03.002_bib2","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2020.03.002_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.semtcvs.2009.07.004","article-title":"Multimodality strategies in malignant pleural mesothelioma","volume":"21","author":"Weder","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejca.2020.03.002_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.21037\/tlcr.2018.04.10","article-title":"Current chemotherapy strategies in malignant pleural mesothelioma","volume":"7","author":"de Gooijer","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ejca.2020.03.002_bib5","doi-asserted-by":"crossref","first-page":"57460","DOI":"10.18632\/oncotarget.15404","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.03.002_bib6","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2009.04.028","article-title":"A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials","volume":"45","author":"Francart","year":"2009","journal-title":"Eur J cancer (Oxford, England: 1990)"},{"key":"10.1016\/j.ejca.2020.03.002_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejca.2020.03.002_bib8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jtho.2016.05.020","article-title":"The genetic landscape of malignant pleural mesothelioma: results from massively parallel sequencing","volume":"11","author":"Hylebos","year":"2016","journal-title":"J Thorac Oncol: Off Publ Int Assoc Stud Lung Cancer"},{"key":"10.1016\/j.ejca.2020.03.002_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010612","article-title":"Second generation sequencing of the mesothelioma tumor genome","volume":"5","author":"Bueno","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.ejca.2020.03.002_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Canc Res"},{"key":"10.1016\/j.ejca.2020.03.002_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JTO.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study","volume":"10","author":"Lo Iacono","year":"2015","journal-title":"J Thorac Oncol: Off Publ Int Assoc Stud Lung Cancer"},{"key":"10.1016\/j.ejca.2020.03.002_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Canc Discov"},{"key":"10.1016\/j.ejca.2020.03.002_bib13","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.ejca.2020.03.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejca.2020.03.002_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","article-title":"Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients","volume":"9","author":"Bovolato","year":"2014","journal-title":"J Thorac Oncol: Off Publ Int Assoc Stud Lung Cancer"},{"key":"10.1016\/j.ejca.2020.03.002_bib16","first-page":"128","article-title":"Tumours of the lung, pleura, thymus and heart","author":"William","year":"2004","journal-title":"Pathol Genet"},{"key":"10.1016\/j.ejca.2020.03.002_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003","article-title":"Contemporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma","volume":"11","author":"Bille","year":"2016","journal-title":"J Thorac Oncol: Off Publ Int Assoc Stud Lung Cancer"},{"key":"10.1016\/j.ejca.2020.03.002_bib18","first-page":"232","article-title":"The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma","volume":"1845","author":"de Assis","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejca.2020.03.002_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","article-title":"Functional inactivation of NF2\/merlin in human mesothelioma","volume":"64","author":"Thurneysen","year":"2009","journal-title":"Lung Canc (Amsterdam, Netherlands)"},{"key":"10.1016\/j.ejca.2020.03.002_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2020.03.002_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ejso.2019.02.025","article-title":"UQCRC1 downregulation is correlated with lymph node metastasis and poor prognosis in CRC","volume":"45","author":"Li","year":"2019","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.ejca.2020.03.002_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cbi.2010.03.047","article-title":"Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis","volume":"188","author":"Liu","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ejca.2020.03.002_bib23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12272-018-1058-7","article-title":"Genome-wide evidences of bisphenol a toxicity using Schizosaccharomyces pombe","volume":"41","author":"Kim","year":"2018","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.ejca.2020.03.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.07.002","article-title":"Integrated genomic analysis of hurthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes","volume":"34","author":"Ganly","year":"2018","journal-title":"Canc Cell"},{"key":"10.1016\/j.ejca.2020.03.002_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF02067351","article-title":"Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior","volume":"16","author":"Herrera","year":"1992","journal-title":"World J Surg"},{"key":"10.1016\/j.ejca.2020.03.002_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3233\/CBM-150504","article-title":"Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers","volume":"15","author":"He","year":"2015","journal-title":"Canc Biomarkers: Sec A Dis Markers"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492030143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492030143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:27:43Z","timestamp":1760732863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492030143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":26,"alternative-id":["S095980492030143X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.002","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}